Principal Investigator
Peter Hosein
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20260647
Clinical Trial Summary
Expanded Access Program To Treat Patients With Previously Treated Metastatic Pancreatic Adenocarcinoma With Daraxonrasib
Phase
Other
Funding Agency/Sponsor
Industrial
Disease
Pancreatic, Liver, and Related Cancers
Contact Information
Phone Number
+1 (305) 2433462